Pear Therapeutics

Pear Therapeutics

Pear Therapeutics

Pear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need.
Suggest edits
Type
B2c
Founded
2013
Raised
$234M
Follow us
Also headquartered in Boston
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5

Add info
Add round
08 Dec 2020
$80,000,000
Venture capital (Series D)
Temasek Holdings, Pilot House Ventures, Novartis, +7

Pear Therapeutics raises $80M in push for reimbursement

MedCity News
+1
04 Jan 2019
$64,000,000
Venture capital (Series C)
Temasek Holdings, Novartis, EDBI, +9

Pear Therapeutics locks in $64 mln Series C

PE HUB
02 Jan 2018
$50,000,000
Venture capital (Series B)
Novartis, EDBI, 5AM Ventures, +4

| PEAR Therapeutics scores $50 mln Series B

PE HUB
03 Feb 2016
$20,000,000
Venture capital
5AM Ventures, Arboretum Ventures, Jazz Venture Partners, +1

The Daily Startup: Pear Therapeutics Aims for Digital Substance-Abuse Treatment

VentureWire
+1
03 Feb 2016
$20,000,000
Venture capital (Series UNDISCLOSED)
5AM Ventures, Arboretum Ventures, Jazz Venture Partners, +1

Digital Therapeutics Pioneer Pear Therapeutics Raises $20M

PRWeb